David Maris - The billion-dollar opportunity for Hims that Wall Street is "sleeping" on — Hims House

✨ AI Summary

Analyst David Maris revisits Hims' GLP-1 timeline and Novo partnership.
He debates margins and the impact of the FDA/DOJ referral.
Maris believes Wall Street is overlooking a billion-dollar opportunity for Hims.

Guests on This Episode

DM

David Maris

1 podcast appearance

Aug 7, 2026 · 0:54:27

Jul 27, 2026 · 0:59:34

Jul 15, 2026 · 1:01:14

Jul 7, 2026 · 1:00:30